| Combination of | |
|---|---|
| Bazedoxifene | Selective estrogen receptor modulator |
| Conjugated estrogens | Estrogen |
| Clinical data | |
| Trade names | Duavee, Duavive |
| AHFS/Drugs.com | Professional Drug Facts |
| MedlinePlus | a614004 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| KEGG | |
Bazedoxifene/conjugated estrogens, sold under the brand name Duavee in the US and Duavive in the EU, is a fixed-dose combination medication for the treatment of menopause symptoms and postmenopausal osteoporosis.[4][5][6] It contains the selective estrogen receptor modulator bazedoxifene and conjugated estrogens. It is taken by mouth.
The combination was approved for medical use in the United States in October 2013,[7] and in the European Union in December 2014.[3]
See also[edit]
References[edit]
- ^ "Bazedoxifene / conjugated estrogens (Duavee) Use During Pregnancy". Drugs.com. 16 February 2019. Retrieved 23 June 2020.
- ^ "Duavee- conjugated estrogens/bazedoxifene tablet, film coated". DailyMed. 16 July 2021. Retrieved 21 February 2022.
- ^ a b "Duavive EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 10 June 2020.
- ^ "Duavee. Generic Name: conjugated estrogens and bazedoxifene tablets". rxlist.com.
- ^ Palacios S, Mejía Ríos A (February 2015). "Bazedoxifene/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women". Drugs of Today. 51 (2): 107–16. doi:10.1358/dot.2015.51.2.2281023. PMID 25756066.
- ^ Lello S, Capozzi A, Scambia G (2017). "The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause". International Journal of Endocrinology. 2017: 5064725. doi:10.1155/2017/5064725. PMC 5735652. PMID 29358948.
- ^ "Drug Approval Package: Duavee (conjugated estrogens and bazedoxifene) NDA #022247". U.S. Food and Drug Administration (FDA). 7 October 2013. Retrieved 23 June 2020.
External links[edit]
- "Bazedoxifene mixture with conjugated estrogens". Drug Information Portal. U.S. National Library of Medicine.
